Exponent Sees Q3 FY26 Revenue Before Reimbursements Growth Of 8%-10%; Raises FY26 Revenue Before Reimbursements Growth View To 9%-10%
Exponent, Inc.
Exponent, Inc. EXPO | 0.00 |
Exponent (NASDAQ:EXPO) expects third-quarter fiscal 2026 revenues before reimbursements to increase 8% to 10% year over year. The company also raised its full-year fiscal 2026 outlook and now expects revenues before reimbursements to grow 9% to 10% from fiscal 2025.